Cargando…
Pharmacometrics: A New Era of Pharmacotherapy and Drug Development in Low- and Middle-Income Countries
Pharmacotherapy, in many cases, is practiced at a suboptimal level of performance in low- and middle-income countries (LMICs) although stupendous amounts of data are available regularly. The process of drug development is time-consuming, costly, and is also associated with loads of hurdles related t...
Autores principales: | Usman, Muhammad, Khadka, Sitaram, Saleem, Mohammad, Rasheed, Huma, Kunwar, Bimal, Ali, Moshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014156/ https://www.ncbi.nlm.nih.gov/pubmed/36925562 http://dx.doi.org/10.1155/2023/3081422 |
Ejemplares similares
-
Preventing COVID-19 in low- and middle-income countries
por: Khadka, Sitaram, et al.
Publicado: (2020) -
Editorial: Pharmacometrics—tools to assure optimal medicine use in low- and middle-income countries
por: Abulfathi, Ahmed A., et al.
Publicado: (2022) -
Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries
por: Adhikari, Sugat, et al.
Publicado: (2020) -
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
por: Rasheed, Huma, et al.
Publicado: (2018) -
Application of Pharmacometrics in Pharmacotherapy: Open-Source Software for Vancomycin Therapeutic Drug Management
por: Bae, Soo Hyeon, et al.
Publicado: (2019)